Schwartzberg, L. S., & Kiedrowski, L. A. (2021). Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation. Ther Adv Med Oncol.
استشهاد بنمط شيكاغوSchwartzberg, Lee S., و Lesli A. Kiedrowski. "Olaparib in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer With a Somatic BRCA2 Mutation." Ther Adv Med Oncol 2021.
MLA استشهادSchwartzberg, Lee S., و Lesli A. Kiedrowski. "Olaparib in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer With a Somatic BRCA2 Mutation." Ther Adv Med Oncol 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.